VC investments plunge 51 pct to $3.7 billion in 2Q

Jul 21, 2009 By MICHAEL LIEDTKE , AP Business Writer

(AP) -- Venture capitalists cut their U.S. investments in half during the spring, the second-consecutive quarter to mark a more than 50 percent decline, leaving the money flowing to startups at the slowest trickle in 12 years.

Nearly $3.7 billion poured into 612 venture-capital deals in the three months ending in June, according to statistics released Tuesday by PricewaterhouseCoopers, Thomson Reuters and the National Venture Capital Association.

The dollars invested represented a 51 percent drop from more than $7.5 billion during the same period last year. The erosion followed the first quarter's year-over-year decline of 58 percent to $3.2 billion.

It's the first time U.S. venture capitalists have invested less than $7 billion during the first half of a year since they anted up $6.5 billion from January through June in 1997.

After that, the dot-com boom unleashed a flood of venture capital that culminated in the dot-com bust in 2001. Venture capitalists been investing between $9 billion and $15 billion during the first halves of the years since then.

Venture capitalists have become more cautious as the worst U.S. since World War II has unfolded. The horrible economy has made it tougher for startups to complete initial public offerings of stock or find buyers. The paucity of IPOs and buyouts have made it increasingly difficult for venture capitalists to cash out of their existing investments, giving them less incentive to finance new deals.

"We desperately need the IPO market to come back, but I'm not looking for it yet," said David Jones Jr., managing director of Chrysalis Ventures in Louisville, Ky.

With more startups forced to remain private, entrepreneurs with fresh ideas are having trouble lining up financing.

Later-stage startups accounted for about one-third of the venture capital deals completed in the second quarter.

Biotechnology received the most venture capital in the quarter at $888 million, down 16 percent from the same time last year. Venture capitalists are still gravitating toward biotechnology because large pharmaceutical companies remain interested in buying startups that are developing promising drugs.

Interest in the Internet has cooled, with curtailing their second-quarter investments in the sector by 68 percent to $524 million.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Amazon launches 3D printing store

add to favorites email to friend print save as pdf

Related Stories

Venture capital in nano rises

Jan 10, 2006

Venture capital investment for nanotechnology rose strongly in 2005, with institutional venture capitalists devoting $480 million into nanotechnology startups last year, up from roughly $410 million spent in 2004, experts ...

Analysts expect to see more wireless IPOs

Feb 24, 2006

Investment in the wireless technology industry is on the rise, and analysts expect to see more companies issuing initial public offerings on the stock market.

Nano World: $30 billion in nano goods

May 10, 2006

Emerging nanotechnology made its way into more than $30 billion in manufactured goods in 2005, more than double the year before, experts tell UPI's Nano World.

Israeli, U.S. venture firms open joint lab

Mar 02, 2006

An Israeli venture-capital firm and a U.S. venture-capital company announced Wednesday they would join forces to invest millions in 10 new tech startups.

Recommended for you

Pfizer's 2Q profit sinks 79 pct but tops forecasts

2 hours ago

(AP)—Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion. The latest results still edged ...

Aetna 2Q profit rises 2.4 percent

2 hours ago

Aetna's second-quarter profit climbed more than 2 percent, as gains from an acquisition helped the health insurer beat analyst expectations and raise its 2014 earnings forecast again.

Merck 2Q profit more than doubles

2 hours ago

A big one-time gain and a tax benefit helped drugmaker Merck & Co. more than double its second-quarter profit, raise the lower end of its profit forecast and easily top analysts' expectations.

Amazon launches 3D printing store

23 hours ago

Amazon announced Monday the launch of an online store for 3D printed items to allow consumers to customize and personalize items like earrings, pendants, dolls and other objects.

User comments : 0